Diovan Hct
Product Images NDC 68258-6053

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Diovan Hct (NDC 68258-6053). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ndc 68258-6053-xx (Ndc 68258 6053 Xx Novartis)

This is a description of a medication distributed by Novartis Pharmaceuticals Corporation. The medication is an ovaloid tablet with slightly convex faces, debossed with NVR/HXH. The medication is called DIOVAN HCT 160 mg/25 mg and contains Valsartan USP and Hydrochlorothiazide USP. It is dispensed in a tight and light-resistant container and should be taken orally once daily. The medication can cause drowsiness, dizziness, or headache and should not be discontinued without a doctor's advice. It is also warned that the medicine should be kept out of children's reach and stored at 77°F.*

FDA Label Image

Figure 1: Probability Of Achieving Systolic Blood Pressure <140 Mmhg At Week 8 (Diovan Hct 01)

FDA Label Image

Figure 2: Probability Of Achieving Diastolic Blood Pressure <90 Mmhg At Week 8 (Diovan Hct 02)

FDA Label Image

Figure 3: Probability Of Achieving Systolic Blood Pressure <130 Mmhg At Week 8 (Diovan Hct 03)

FDA Label Image

Figure 4: Probability Of Achieving Diastolic Blood Pressure <80 Mmhg At Week 8 (Diovan Hct 04)

FDA Label Image

Valsartan Structural Formula (Diovan Hct 05)

FDA Label Image

Hydrochlorothiazide Structural Formula (Diovan Hct 06)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.